Defining CRO selection criteria starts before you write an RFP. If you do not decide what "right" looks like for your program, the first CRO capability presentation you see will decide it for you. In the ABRA PROOF™ Method, Position the Program is the first stage: we define what "right" looks like before any CRO sees the study, and you sign off the selection criteria before any bid arrives.
I have watched this play out many times. A sponsor takes a few introductory calls, sees an impressive platform demonstration and an elegant therapeutic case study, and begins evaluating every other CRO against that one. Nobody decided that platform mattered most. It simply arrived first.
What does "right" mean in CRO selection?
"Right" is never universal. The right CRO for a 200-site global Phase 3 program is rarely right for a 12-site Phase 1b in a rare disease. Defining it means answering a handful of program-specific questions honestly.
What must go right for this study to succeed? Enrollment in a narrow population, complex dosing logistics, a novel endpoint, speed to a financing readout. Name the critical few.
Where is your internal capacity thin? If you have no in-house data management or medical monitoring, those capabilities carry more weight in your evaluation.
What does the next milestone require? A study designed to support a financing round has different priorities than one designed to inform a partnering decision.
What are your non-negotiables? Geography, regulatory experience, specific technology integrations or a requirement for senior oversight on your account.
Why should sponsors define selection criteria before the RFP?
There are three practical reasons.
First, it protects objectivity. Criteria written after you have met bidders tend to favor whoever made the best impression.
Second, it improves proposals. CROs respond to what you ask. A sponsor who states clearly what matters most receives proposals that address those priorities directly, instead of generic capability narratives.
Third, it aligns your internal team. Clinical, regulatory, finance and executive leaders often weight things differently without realizing it. Surfacing that early prevents a late disagreement that stalls the award.
What are the most common mistakes in defining CRO requirements?
The most common mistake is treating every criterion as equally important. When everything matters, nothing differentiates. A short list of weighted priorities is far more useful than a long list of desirable features.
Another is letting budget alone define the target. Cost matters, but a sponsor who leads with price will receive proposals optimized for price, often at the expense of the assumptions that protect your timeline.
A third is skipping the conversation about risk appetite. Some sponsors will trade a higher budget for greater delivery certainty. Others need every dollar for runway. Both positions are legitimate, but the CRO you choose should match the one you hold.
What sponsors gain from Position the Program
When Position the Program is done well, you leave the stage with selection criteria you signed before any bid arrived. Every proposal, presentation and reference conversation that follows has a standard to be measured against, and no bidder gets to redefine it along the way. When your board later asks why you chose your CRO, the rationale traces back to priorities your team agreed on in writing.
That signed foundation carries through the rest of PROOF™. Right-sizing the field, comparing bids line by line and reconciling assumptions in the contract all depend on knowing, and having agreed, what "right" means for you.
Turn your priorities into weighted criteria with the free CRO Selection Scorecard.
